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Abstract
BACKGROUND—Genome-wide association studies have identified several genetic loci
associated with variation in resting heart rate in European and Asian populations. No study has
evaluated genetic variants associated with heart rate in African Americans.
OBJECTIVE—To identify novel genetic variants associated with resting heart rate in African
Americans.
METHODS—Ten cohort studies participating in the Candidate-gene Association Resource and
Continental Origins and Genetic Epidemiology Network consortia performed genome-wide
genotyping of single nucleotide polymorphisms (SNPs) and imputed 2,954,965 SNPs using
HapMap YRI and CEU panels in 13,372 participants of African ancestry. Each study measured
the RR interval (ms) from 10-second resting 12-lead electrocardiograms and estimated RR-SNP
associations using covariate-adjusted linear regression. Random-effects meta-analysis was used to
combine cohort-specific measures of association and identify genome-wide significant loci (P ≤
2.5 × 10−8).
RESULTS—Fourteen SNPs on chromosome 6q22 exceeded the genome-wide significance
threshold. The most significant association was for rs9320841 (+13 ms per minor allele; P = 4.98
× 10−15). This SNP was approximately 350 kb downstream of GJA1, a locus previously identified
as harboring SNPs associated with heart rate in Europeans. Adjustment for rs9320841 also
attenuated the association between the remaining 13 SNPs in this region and heart rate. In
addition, SNPs in MYH6, which have been identified in European genome-wide association study,
were associated with similar changes in the resting heart rate as this population of African
Americans.
CONCLUSIONS—An intergenic region downstream of GJA1 (the gene encoding connexin 43,
the major protein of the human myocardial gap junction) and an intragenic region within MYH6
are associated with variation in resting heart rate in African Americans as well as in populations of
European and Asian origin.
Keywords
African Americans; Heart rate; Single nucleotide polymorphisms; Meta-analysis
Introduction
Multiple studies have found that an elevated resting heart rate is associated with mortality
risk1–5 including that attributable to sudden cardiac death6 and cardiovascular disease.7
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These findings suggest that the function of the sinus node, the dominant pacemaker in the
heart, and the autonomic nervous system are associated with adverse clinical outcomes.
Although nongenetic influences of nodal and autonomic function are well known,8 genetic
factors account for 26%–32% of the variation in resting heart rate in populations of
European and Asian ancestry.9–11 Genome-wide association studies (GWASs) conducted in
populations of European and Asian ancestry have recently identified single nucleotide
polymorphisms (SNPs) associated with resting heart rate at several loci including GJA1 on
chromosome 6, MYH6 on chromosome 14, CD34 on chromosome 1, and GPR133 on
chromosome 12.12–15 To the best of our knowledge, however, no study has evaluated the
association of genetic variants with heart rate among populations of African descent. Such
populations have greater genetic diversity compared to those of European and Asian origin,
which may facilitate identification of additional associated loci.16–18 It is also unclear
whether loci identified in populations of European and Asian ancestry are relevant in
populations of African descent.
In an attempt to identify new loci and evaluate existing, known associations, we examined
the association of genetic variants with resting heart rate as measured by the RR interval on
the electrocardiogram (ECG) among 10 African American cohort studies participating in the
Candidate-gene Association Resource (CARe) and the Continental Origins and Genetic
Epidemiology Network (COGENT) ECG consortia.
Methods
Study populations
The CARe19 and COGENT20 consortia included 13,372 self-reported African Americans
meeting inclusion criteria. The participants originated in 10 cohort studies: the
Atherosclerosis Risk in Communities study (ARIC; n = 2391); Baltimore Longitudinal
Study of Aging (BLSA; n = 155); Bogalusa Heart Study (BHS; n = 148); Cardiovascular
Health Study (CHS; n = 674); Cleveland Family Study (CFS; n = 267); the Health, Aging,
and Body Composition Study (Health ABC; n = 1054); the Healthy Aging in
Neighborhoods of Diversity across the Life Span Study (HANDLS; n = 945); Jackson Heart
Study (JHS; n = 1962); Multi-Ethnic Study of Atherosclerosis (MESA; n = 1627); and
Women’s Health Initiative clinical trials (WHI; n = 4149). Additional information is
provided in the Supplemental Methods, including cohort-specific genotype and imputation
quality control methods (see Online Supplements 1 and 2). Participants with missing
covariates, poor-quality ECGs, pacemakers or implantable cardioverter-defibrillators,
paroxysmal or persistent atrial fibrillation, heart failure, myocardial infarction, second- or
third-degree atrioventricular block, and extremes of heart rate (>100 or <50 beats/min) were
excluded. Participants on medications altering nodal or atrioventricular conduction (beta-
blockers, nondihydropyridine calcium channel blockers, digoxin, type I or III
antiarrhythmics) were also excluded.
The study was approved by the institutional review boards at each participating center.
Written informed consent was obtained from all participants.
ECG recordings
A standard 10-second, resting ECG was obtained and recorded digitally on all participants
from the 10 cohorts included in this analysis. Standard 12-lead positions were recorded at
baseline in all cohort studies using a Marquette MAC PC, MAC6, or MAC1200 ECG
machine system (GE Healthcare, Milwaukee, WI). The RR interval (ms) was measured
electronically as the unit-corrected inverse of heart rate (beat/min). All ECGs were
processed automatically using GE Marquette 12-SL version 2001 running under GE
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Magellan Research Work Station or MC Means. The ECG software is Food and Drug
Association approved. Heart rate was calculated from the median RR interval during the 10-
second recording. Since ECG recordings were simultaneous in all 12 leads, the rate was not
affected by the lead from which the RR interval was recorded. The automated nature of
calculating heart rate from the median RR interval ensures the highest repeatability with no
inter- or intraobserver variability. Poor-quality ECGs were excluded by software algorithms.
As an added quality control measure, all ECGs were visually checked.
After a filtering process that results in signal conditioning and averaging, the program
generates a median complex. All QRSs of the same shape are aligned in time and the
interval measurements depend on the proper identification of fiduciary points, which are
determined from an analysis of all 12 leads simultaneously. The intervals are then measured
according to published standards.21
Genotyping and quality control
Genome-wide SNP genotyping was performed within each cohort using genotyping arrays
from Affymetrix or Illumina (Online Supplement 2). Studies underwent similar quality
control procedures (specific details in the Online Supplemental Materials). DNA samples
with an array-wide genotyping success rate <95% were excluded. Autosomal heterozygosity
rates were estimated to identify and exclude samples with poor DNA quality or
contamination. Duplicated or contaminated samples were identified from identity by descent
estimates and excluded. In addition, SNPs with a genotyping success rate <90% per SNP
within each cohort, SNPs that map to multiple locations, SNPs where missingness could be
predicted from surrounding haplotypes, and SNPs associated with chemistry plates were
excluded. African ancestry was confirmed through either principal components22 or
multidimensional scaling analyses. Population-based (ie, non-family-based) studies used
identity-by-descent (IBD) estimates to exclude cryptically related individuals. Subsequent
identical SNP filters after imputation and GWAS analyses were applied to summary
statistics at the meta-analysis level.
Imputation and quality control
SNP imputation was performed in each cohort to facilitate the combination of results from
different genotyping platforms and to increase genotype coverage. Genotyped SNPs passing
quality control metrics described above and reference haplotypes from HapMap Phase 2
(release 22 on NCBI build 36) were used to impute approximately 2.5 million SNPs using
MACH v1.1623 or BEAGLE. Untyped SNPs were imputed using a 1:1 ratio of CEU/YRI
HapMap reference haplotypes based on consistency across other CARe-COGENT studies.
Imputed SNPs were excluded if imputation quality was below 0.30 as reported by MACH or
BEAGLE.
Statistical analysis
GWAS analysis was performed in either PLINK (ARIC, BHS, CHS, JHS, WHI), R
(HANDLS, Health ABC, MESA), ProbA-BEL (WHI), or MERLIN (BLSA) using linear
regression with an additive genetic model based on allelic dosages accounting for
imputation uncertainty. The family-based CFS study was analyzed using linear mixed-
effects models as implemented in the GWAF package for R.24 Pedigrees for CFS were
confirmed using identity by state or IBD estimates from PREST-Plus (http://
www.utstat.utoronto.ca/sun/Software/Prest/). Previously published analyses indicated that
the inclusion of related individuals from the JHS family-based subcohort had little effect on
P-value inflation.20 As a result, these related individuals were included in the present
analysis. Eigenvectors were used to adjust for global ancestry in population substructures.
Principal components were used to adjust for global ancestry in population stratification.
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Cohort-specific genome-wide association was examined on a SNP-by-SNP basis using
simple linear models regressing RR (ms) on allele dosage, age, sex, body mass index, global
measures of African ancestry, and, when relevant, study site. Cohort-specific SNP
association estimates were combined using fixed- and random-effects meta-analysis, the
latter to examine potential effects of among-cohort heterogeneity on the combined estimates
and the extent to which it can support qualitative inference to other African American
populations. Given evidence of greater genetic and geographical diversity across African
American cohorts compared to Europeans and initial evidence of heterogeneity across
studies, random-effects estimates, which have wider 95% confidence intervals than do fixed-
effects estimates, were reported in the current meta-analysis. Genomic control methods were
applied when study-specific and combined distributions of test statistics suggested early
departure from the null (λ > 1). Genomic inflation factors were evaluated in each cohort
before the random-effects meta-analysis and in the combined results.25 We calculated X2
estimates of homogeneity (Cochran’s Q) using METAL and I2 estimates with R. Prior to
conducting meta-analyses, SNP results with a minor allele frequency <0.01 or imputation
quality scores <0.3 were excluded. In addition, SNPs not seen in >2 studies were excluded
from the meta-analyses.
To confirm that the random-effects model was not overly conservative, standard fixed-
effects meta-analyses were conducted on SNP association estimates for each cohort using
METAL (and incorporating genomic control at the meta-analysis level). For the meta-
analysis, we prespecified a genome-wide significance threshold of 2.5 × 10−8 as suggested
for populations of African ancestry,26 accounting for approximately 2 million independent
common variant tests. Other polymorphisms that were detected at the same locus as the
initial SNP were subsequently analyzed in conditional regression models to assess statistical
independence. Finally, SNPs that have been identified in prior GWAS but not in the
discovery phase of our analysis were evaluated using a less stringent threshold. Specifically,
we evaluated 13 genome-wide significant SNPs described by prior RR GWAS in individuals
of European and Asian ancestry13–15 using a significance level of 3.85 × 10−3 (Bonferroni
corrected P value calculated as 0.05/13).
Results
This GWAS of the RR interval included 13,372 adults of African descent from 10 cohort
studies. Each study contributed a widely varying number of participants (range 148–4149).
The ARIC, JHS, and WHI studies accounted for the majority of participants in this analysis:
8502 (64%) of 13,372. On average, the study population was middle-aged (mean 56.5 years;
range 35–73 years) and overweight (mean body mass index 30.8 kg/m2) and 71% were
women.
Genomic inflation was minimal in most studies and modest in the family-based CFS (λ
1.070) and JHS (λ 1.071) (Table 1). Specifically, the lambda estimates from the random-
effects meta-analysis did not suggest inflation of the test statistic (0.868), and the secondary
fixed-effects modeling did not show a significant departure from null expectations (λ 1.017)
(Figures 1A and 1B).
A total of 2,954,965 SNPs were incorporated into this meta-analysis after data quality
control. Fourteen SNPs at a largely intergenic region on chromosome 6q22 (Figure 2)
reached genome-wide significance. The most significant association at this locus was for
rs9320841 (+13 ms per minor allele, standard error 1.7 ms, random effects P = 4.98 ×
10−15). This SNP is located in a noncoding region, 350 kb downstream from GJA1 and 64
kb upstream from HMGB3P18. The magnitude and direction of the association were similar
across most cohorts (Pheterogeneity = .45) as shown in Figure 3. None of the other 13 SNPs in
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this region were independent variants associated with resting heart rate. The results for the
regional association plot at the GJA1 locus are depicted in Figure 4. This plot covers 1000
kb of the genomic region associated with the GJA1 locus and demonstrates strong linkage
disequilibrium (LD) with other SNPs in this gene cluster that were associated with variations
in heart rate. Adjustment for rs9320841, however, eliminated the significance of these
additional SNPs.
We also evaluated a series of SNPs from the chromosome 6q22 locus that were identified in
prior European and Asian GWAS. Both rs9398652 and rs12110693 in the 6q22 locus were
associated with the RR interval, which were similar to estimates reported in prior studies of
Asian14 and European13 populations; however, only rs9398652 reached genome-wide
significance in the current meta-analysis. The rs9398652 SNP was approximately 30 kb
downstream and in high linkage disequilibrium with the leading SNP from the present study
(rs9320841; CEU r2 = 1.00; YRI r2 = .81). In addition, rs12110693 was in strong linkage
disequilibrium with rs9320841 (rs9320841; CEU r2 = 1.00; YRI r2 = .76) (Table 2). The
final reported SNP from the 6q22 locus, rs11154022, did not reach genome-wide
significance, was the greatest distance from rs9320841 (approximately 365 kb upstream),
and not in LD with it (CEU r2 = .01; YRI r2 = .01).
Other variants that were identified from prior European and Asian GWAS were also tested
(Table 2). The 2 SNPs that have previously been identified at the MYH6 locus (rs452036
and rs365990) were associated with resting heart rate in African Americans using the
replication threshold (3.85 × 10−3). These variants are associated with a similar increase in
the sinus cycle length across Europeans, Asians, and African Americans. We were unable to
confirm associations for several previously published loci at replication thresholds: CD46 on
chromosome 1, SLC35F1 on chromosome 6, SLC12A9 and UfSp1 on chromosome 7,
FADS1 on chromosome 11, an intergenic region on chromosome 12, GPR133 on
chromosome 12, and MYH7 on chromosome 14 (Table 2). These findings were consistent
across the different cohorts analyzed through the CARe-COGENT consortium (Figure 5).
Further evaluation of these loci (the 1 Mb regions, 500 kb upstream and downstream of the
SNPs in Table 2) did not identify any other genome-wide significant RR-SNP associations
despite having adequate power (power > 0.8).
Discussion
In a large GWAS of African Americans, we generalized a previously reported association
between a variant on chromosome 6q22.31 and resting heart rate to a population of African
descent. The present findings suggest that rs9320841, which is located in an intergenic
region 350 kb downstream from GJA1, is the leading SNP at this locus associated with heart
rate. In addition, rs9320841 is in high LD with other intergenic SNPs from this region
previously associated with heart rate in GWAS in populations of European and Asian
ancestry.13,14
Multiple studies including the current report have demon strated intergenic SNPs in
proximity to rs9320841 that are associated with variation in heart rate among individuals of
Asian, European, and African ancestry. The closest putative transcript to rs9320841 on
chromosome 6q22.31 is HMGB3P18, which has no known function. However, GJA1 which
is approximately 350 kb upstream of this SNP, encodes connexin 43, the main cardiac gap
junction channel that is found throughout the heart and is responsible for intercellular con
ductance in the atria and ventricles.27 Connexin 43 is expressed abundantly in the atria and
permits the node to conduct impulses to the surrounding muscle.28 Experimental models
have demon strated that the deletion of various gap junction subunits results in a sick sinus
syndrome phenotype with bradycardia, sinus dysrhythmia, and sinus node exit block.29,30
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As a result, these intergenic variants in the 6q22 locus, which are in close proximity to GJA1
and have been identified across different populations, may reduce sinus automaticity.
Although rs9320841 and previously identified 6q22.31 loci are 300–500 kb away from and
in low LD with SNPs in GJA1 recent studies suggest that variations in intergenic regions
may regulate transcription factor binding and chromatin modifica tion.31 Functional and
translational studies focused on this intergenic region on chromosome 6q22 will be required
to understand its potential effect on GJA1.
In the portion of our study that restricted the analysis to previously identified variants, we
observed an association between 2 SNPs located within the MYH6 gene and resting heart
rate. MYH6 encodes one of the myosin heavy chain subunits in the cardiac sarcomere and is
a major component of the cardiac contractile system. In addition, MYH6 encodes a cardiac-
specific microRNA, miR-208a, which is a key regulatory molecule that is necessary for
normal cardiac conduction.32 Specifically, miR-208a regulates expression of connexin 40, a
gap junction protein that is implicated in sinus automaticity and cardiac arrhythmias.29–33
As a result, changes in the MYH6 genetic architecture could alter microRNA production,
gap junction formation, and sinus node function. Prior GWAS in European populations have
identified common variants in this gene to be associated with resting heart rate13,15 and rare
variants, located 0.3–4.4 kb from these SNPs, to be associated with sick sinus syndrome.34
Although SNPs at the MYH6 locus were not identified in the discovery phase of our
analysis at genome-wide significance thresholds (P < 2.5 × 10−8), the similar magnitude and
direction of the point estimates in our analysis suggest that the MYH6 gene affects sinus
node automaticity in diverse populations.
While we were unable to replicate associations for other previously published loci at a
threshold level of 3.85 × 10−3 (0.05/13), the similar magnitude and direction of the point
estimates suggest consistency across ancestries. Specifically, SLC12A9 and UfSp1 on
chromosome 7 and the MYH7 region on chromosome 14 had effects on heart rate similar to
those described by prior studies. Compared to individuals of European ancestry, however,
African Americans have greater genetic diversity,18 which may lower the frequency of a
particular allele and subsequently reduce the statistical likelihood of detecting an effect on
the RR interval. In addition, linkage disequilibrium is commonly lower in African
Americans35 and subsequently reduces the likelihood that a common SNP is in linkage
disequilibrium with a causal variant. Furthermore, these analyses were conducted in a
population that was predominantly woman, middle-aged, and overweight. This demographic
profile differs from that of prior studies and may have influenced the results.
A common limitation of meta-analyses is among-study phenotype heterogeneity; however,
the current study followed similar electrocardiographic and clinical protocols when
measuring heart rate and its correlates. In addition, the statistical assessment of
heterogeneity did not suggest large variation in SNP effects across studies. Moreover, the
random-effects meta-analysis of these effects was weighted for both their within- and
among-study variation. Another limitation of GWAS is potential for population
stratification, including confounding by ancestry. However, we attempted to minimize bias
from population structure by excluding participants of non-African ancestry, adjusting for
principal components in study-specific regression models, and applying genomic control
methods.
Conclusions
In summary, the genome-wide significance of an association linking resting heart rate and
the GJA1 locus previously described in European and Asian populations has now been
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generalized to African Americans. In addition, this analysis has replicated associations
initially discovered in Europeans between common variants within the MYH6 gene and a
reduction in heart rate to an African American population. Generalizability across global
populations and biological plausibility of the heart rate-GJA1 and heart rate-MYH6
associations highlight the potential importance of these loci in the intrinsic (nodal and
myocardial) determination of resting heart rate.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ARIC Atherosclerosis Risk in Communities study
BHS Bogalusa Heart Study
BLSA Baltimore Longitudinal Study on Aging
CFS Cleveland Family Study
CHS Cardiovascular Health Study
CARe Candidate-gene Association Resource
COGENT Continental Origins and Genetic Epidemiology Network
ECG electrocardiogram
HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span Study
Health ABC Health Aging and Body Composition
GWAS genome-wide association study
JHS Jackson Heart Study
MESA Multi-Ethnic Study of Atherosclerosis
SNP single nucleotide polymorphism
WHI Women’s Health Initiative clinical trials
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Appendix A Supplementary data
Supplementary data associated with this article can be found in the online version at http://
dx.doi.org/10.1016/j.hrthm.2012.11.014.
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QQ plots of meta-analysis using either random-effects (A) or fixed-effects (B) modeling.
The x axis marks the expected values, and the left-hand y axis marks the observed values. A
line originating from the origin and having a slope of 1 is depicted in red.
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Manhattan plot of RR associations for all SNPs. The P values from random-effects meta-
analysis of 2,954,965 successfully imputed or genotyped SNPs in ≥2 cohorts. Red points =
SNPs with P < 2.5 × 10−8 (considered genome-wide significant). Orange points = SNPs with
P values ranging from less than 1 × 10−5 to 2.5 × 10−8. Regions containing red points were
considered genome-wide significant. SNP = single nucleotide polymorphism.
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Forest plot depicting the effect (beta coefficient) of rs9320841 on RR in milliseconds per
allele (95% confidence interval) across the individual cohort studies and overall using
random-effects modeling (I2 = 0). ARIC = Atherosclerosis Risk in Communities study; BHS
= Bogalusa Heart Study; BLSA = Baltimore Longitudinal Study on Aging; CFS = Cleveland
Family Study; CHS = Cardiovascular Health Study; HANDLS = Healthy Aging in
Neighborhoods of Diversity across the Life Span Study; Health ABC = Health Aging and
Body Composition; JHS = Jackson Heart Study; MESA = Multi-Ethnic Study of
Atherosclerosis; WHI = Women’s Health Initiative clinical trials.
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Regional association plots for the RR interval plotted using P values estimated from 13,372
African Americans from 10 studies. Positions are from NCBI build 36. Linkage
disequilibrium and recombination rates are estimated from HapMap phase II data. SNPs are
represented by circles. The large blue diamond is the SNP with the lowest P value. The
circle color represents correlation with the top SNP: blue indicates weak correlation, and red
indicates strong correlation. Recombination rate is plotted in the background, and known
genes in the region are shown at the bottom of the plot. SNP = single nucleotide
polymorphism.
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Forest plot depicting the effect in milliseconds per allele of SNPs achieving genome-wide
significance in European and Asian studies across the individual African American cohorts.
SNP = single nucleotide polymorphism.
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